Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (1)
  • 2024 (7)
  • 2023 (9)
  • 2022 (9)
  • 2021 (10)
  • 2020 (3)

Subject

  • Drug Trafficking (494)
  • Guns/Weapons (115)
  • Guilty Plea (41)
  • Fake Pills (36)
  • OCDETF/Task Force (35)
  • Pharmaceuticals/Pharmacists/Physicians (32)
  • Money Laundering (31)
  • Overdose (28)
  • Major Law Enforcement Operation (16)
  • Take Back Day (12)
  • Outreach/Drug Prevention (10)
  • Gangs (8)
  • Arrests/Convictions - Major (7)
  • Diversion Division (7)
  • Fentanyl Awareness (7)
  • Dark Web- Internet Trafficking (5)
  • Synthetic drugs (5)
  • One Pill Can Kill (3)
  • Prevention/Education - DEA websites GSAD, JTT etc (3)
  • Seizures (Drugs/Property) (3)
  • Asset Forfeiture (2)
  • Campaigns (1)
  • Counterfeit Pills (1)
  • Fentanyl Free America (1)
  • Narcoterrorism (1)
  • Press Conferences (1)
  • Prescription Drugs (39)

Drug Name

  • Fentanyl (11)
  • Oxycodone (8)
  • Benzodiazepines (3)
  • Hydromorphone (3)
  • Morphine (3)
  • Amphetamines (1)
  • Methadone (1)
  • Methamphetamine (1)
  • Opioids (1)
  • Synthetic Opioids (1)

Field Division

  • Washington, DC (45)
  • New York (34)
  • New England (24)
  • Seattle (23)
  • Sede (21)
  • Atlanta (19)
  • Miami (18)
  • Chicago (16)
  • Dallas (15)
  • New Jersey (15)
  • El Paso (13)
  • Houston (12)
  • San Francisco (12)
  • Louisville (10)
  • Los Angeles (9)
  • Omaha (9)
  • New Orleans (8)
  • Phoenix (6)
  • Rocky Mountain (6)
  • San Diego (6)
  • Detroit (3)
  • Philadelphia (1)
  • St. Louis (39)
Clear All Results
PRESS RELEASE

Woman Sentenced for Selling Prescription Drugs

Septiembre 09, 2022
ST. LOUIS -- U.S. District Judge Sarah E. Pitlyk on Friday sentenced a woman from St. Charles, who fraudulently obtained prescription drugs for herself and her children and then sold them to others, including an undercover agent, to two years of probation, including four months of home detention, and 20...
Septiembre 09, 2022
PRESS RELEASE

Osteopathic Physician Sentenced for Illegally Prescribing Drug

Septiembre 07, 2022
ST. LOUIS – U.S. District Judge Ronnie L. White on Wednesday sentenced an osteopathic physician from Collinsville, Illinois, to a year in prison for illegally prescribing an anti-anxiety drug. Matthew Steven Miller, 43, wrote prescriptions for the anti-anxiety drug Xanax for six people who were not his patients between 2016...
Septiembre 07, 2022
PRESS RELEASE

Collinsville Osteopathic Physician Admits Illegally Prescribing Drug

Julio 07, 2022
ST. LOUIS – An osteopathic physician from Collinsville, Illinois, pleaded guilty in U.S. District Court Tuesday and admitted illegally prescribing an anti-anxiety drug. Matthew Steven Miller, 43, pleaded guilty in front of U.S. District Judge Ronnie L. White to one count of obtaining a controlled substance by fraud and one...
Julio 07, 2022
PRESS RELEASE

Jury Convicts State Lawmaker of COVID-19 Fraud Scheme at Springfield Health Care Charity

Junio 28, 2022
SPRINGFIELD, Mo. – A Missouri state representative was convicted by a federal trial jury today for a nearly $900,000 COVID-19 fraud scheme, as well as a separate $200,000 fraud scheme in which she made false claims about a fake stem cell treatment marketed through her clinics in southern Missouri, and...
Junio 28, 2022
PRESS RELEASE

Collinsville Osteopathic Physician Admits Illegally Prescribing Drug

Junio 07, 2022
ST. LOUIS – An osteopathic physician from Collinsville, Illinois, pleaded guilty in U.S. District Court Tuesday and admitted illegally prescribing an anti-anxiety drug. Matthew Steven Miller, 43, pleaded guilty to one count of obtaining a controlled substance by fraud and one count of making a false statement concerning a health...
Junio 07, 2022
PRESS RELEASE

Pharmacist Indicted for Tampering with a Controlled Substance

Febrero 16, 2022
KANSAS CITY, Kan. – A federal grand jury in Kansas City returned an indictment charging a pharmacist with one count of tampering with a consumer product, one count of possession of tramadol by deception and subterfuge, one count of possession of zolpidem by deception and subterfuge, and one count of...
Febrero 16, 2022
PRESS RELEASE

Nixa Physician Pleads Guilty to Making a False Statement Related to Healthcare and Conspiracy

Diciembre 08, 2021
SPRINGFIELD, Mo. – A Nixa, Missouri, physician pleaded guilty in federal court yesterday to making a false statement to Medicare to obtain insurance coverage for a fentanyl prescription and to conspiring with others to use his DEA registration number to issue Schedule II controlled substances to patients in his absence...
Diciembre 08, 2021
PRESS RELEASE

Man Indicted for Taking Controlled Substances from Kansas Hospital

Noviembre 01, 2021
KANSAS CITY, Kan. – A federal grand jury in Kansas returned an indictment charging an Overland Park, Kansas, man on two counts of tampering with a consumer product, one count of possession of fentanyl by deception and subterfuge, and one count of possession of hydromorphone by deception and subterfuge. According...
Noviembre 01, 2021
PRESS RELEASE

Missouri Woman Indicted for Tampering with Hospitals’ Fentanyl

Octubre 04, 2021
KANSAS CITY, Kan. – A federal grand jury in Kansas City, Kansas, returned an indictment charging a nurse from Kansas City, Missouri, with two counts of tampering with a consumer product and two counts of possession of fentanyl by deception and subterfuge. According to court documents, between January 2020 and...
Octubre 04, 2021
PRESS RELEASE

Creve Coeur Pharmacy and Owner to Pay $1.4 Million for Ignoring Signs of Illegal Drug Prescriptions

Octubre 04, 2021
ST. LOUIS – Olive Street Pharmacy, LLC, and pharmacy technician Irina Shlafshteyn, agreed to pay $1,507,808.50 to resolve a civil complaint bringing claims under the False Claims Act and Controlled Substances Act related to the unlawful dispensing of controlled substances, including some that were submitted to Medicaid or Medicare for...
Octubre 04, 2021
Showing 21 - 30 of 39 results

Paginación

  • Primera página «
  • Página anterior ‹
  • Página 1
  • Página 2
  • Current page 3
  • Página 4
  • Siguiente página ›
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster